COMPREHENSIVE TUBERCULOSIS-CONTROL FOR PATIENTS AT HIGH-RISK FOR NONCOMPLIANCE

被引:63
作者
SCHLUGER, N
CIOTOLI, C
COHEN, D
JOHNSON, H
ROM, WN
机构
[1] NYU,MED CTR,BELLEVUE CHEST SERV,NEW YORK,NY
[2] NYU,MED CTR,DIV PULM & CRIT CARE MED,NEW YORK,NY
关键词
D O I
10.1164/ajrccm.151.5.7735604
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The current tuberculosis epidemic in the United States is marked, in many areas, by high rates of noncompliance with antituberculous regimens. In response to this, a comprehensive program of medical, nursing, social services, and supervised therapy was developed at Bellevue Hospital. Most patients were referred to the on-site directly observed therapy program (DOT) located in the hospital. Patients on DOT received daily or twice weekly therapy, and were given incentives to enhance compliance. Outreach was used to track patients who missed appointments. From November 1992 through July 1993, 113 patients were referred. HIV infection, homelessness, illicit drug use, and alcoholism were common. Follow-up revealed that 11 patients were noncompliant and completely lost to follow-up; of the remaining 102, 99% achieved bacteriologic cure. Of the 102 patients who received therapy, 74 attended the Bellevue DOT clinic, 16 attended other DOT programs in the city or received medication at home, and three died of HIV-related, nontuberculous illness. Nine patients were self-medicated and judged treatment successes. We conclude that a comprehensive hospital-based tuberculosis control program is capable of achieving a high degree of success, even in a population at high risk for noncompliance.
引用
收藏
页码:1486 / 1490
页数:5
相关论文
共 21 条
[1]   PATIENT COMPLIANCE - MOST SERIOUS REMAINING PROBLEM IN THE CONTROL OF TUBERCULOSIS IN THE UNITED-STATES [J].
ADDINGTON, WW .
CHEST, 1979, 76 (06) :741-743
[2]   CONTROL OF TUBERCULOSIS - THE LAW AND THE PUBLICS HEALTH [J].
ANNAS, GJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) :585-588
[3]   TUBERCULOSIS - COMMENTARY ON A REEMERGENT KILLER [J].
BLOOM, BR ;
MURRAY, CJL .
SCIENCE, 1992, 257 (5073) :1055-1064
[4]   RESURGENT TUBERCULOSIS IN NEW-YORK-CITY - HUMAN-IMMUNODEFICIENCY-VIRUS, HOMELESSNESS, AND THE DECLINE OF TUBERCULOSIS-CONTROL PROGRAMS [J].
BRUDNEY, K ;
DOBKIN, J .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04) :745-749
[5]   A 62-DOSE, 6-MONTH THERAPY FOR PULMONARY AND EXTRAPULMONARY TUBERCULOSIS - A TWICE-WEEKLY, DIRECTLY OBSERVED, AND COST-EFFECTIVE REGIMEN [J].
COHN, DL ;
CATLIN, BJ ;
PETERSON, KL ;
JUDSON, FN ;
SBARBARO, JA .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :407-415
[6]  
CONCATO J, 1993, AM REV RESPIR DIS, V147, pA917
[7]   DRUG-TREATMENT OF TUBERCULOSIS - 1992 [J].
DAVIDSON, PT ;
LE, HQ .
DRUGS, 1992, 43 (05) :651-673
[8]   WHY PATIENTS DONT TAKE PILLS [J].
DUDLEY, DL .
CHEST, 1979, 76 (06) :744-749
[9]   THE EMERGENCE OF DRUG-RESISTANT TUBERCULOSIS IN NEW-YORK-CITY [J].
FRIEDEN, TR ;
STERLING, T ;
PABLOSMENDEZ, A ;
KILBURN, JO ;
CAUTHEN, GM ;
DOOLEY, SW .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) :521-526
[10]   TREATMENT OF 171 PATIENTS WITH PULMONARY TUBERCULOSIS RESISTANT TO ISONIAZID AND RIFAMPIN [J].
GOBLE, M ;
ISEMAN, MD ;
MADSEN, LA ;
WAITE, D ;
ACKERSON, L ;
HORSBURGH, CR .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) :527-532